Healthcare Wire Texas
SEE OTHER BRANDS

Exploring the health and wellness news of Texas

Healthcare Wire Texas: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Wire Texas.

Press releases published on April 22, 2025

AI-CVD™ opportunistic detection of fatty liver in coronary calcium scans predicts cardiovascular events and mortality

AI-CVD™ opportunistic detection of fatty liver in coronary calcium scans predicts cardiovascular events and mortality

Research shows HeartLung.AI’s AI-CVD™ improves traditional calcium scores in predicting heart disease risk and all-cause mortality HOUSTON, TX, UNITED STATES, April 22, 2025 /⁨EINPresswire.com⁩/ -- Naghavi M, Atlas K, Reeves A, Zhang C, Wasserthal J, …

Guidehealth Partners with Koda Health to Bring Advance Care Planning to Health Systems and Value-based Care Networks

Guidehealth Partners with Koda Health to Bring Advance Care Planning to Health Systems and Value-based Care Networks

Health systems and CINs working with Guidehealth can integrate Koda Health to amplify patient decision-making, improve outcomes and lower total cost of care. DALLAS AND HOUSTON, TX, UNITED STATES, April 22, 2025 /⁨EINPresswire.com⁩/ -- Guidehealth, a …

FlareCare Empowers Smarter Gut Health Tracking With AI

FlareCare Empowers Smarter Gut Health Tracking With AI

AI Helping People with IBD, IBS, Crohn’s, Colitis, GERD, and Food Intolerances FORT WORTH, TX, UNITED STATES, April 22, 2025 /⁨EINPresswire.com⁩/ -- FlareCare, the innovative mobile app designed to help individuals take control of their gut health, is now …

Moyae Announces Integration with AdvancedMD to Streamline Vision-Care Practice Workflows

Moyae Announces Integration with AdvancedMD to Streamline Vision-Care Practice Workflows

AUSTIN, TX, UNITED STATES, April 22, 2025 /⁨EINPresswire.com⁩/ -- Moyae, the AI-powered electronic health record (EHR) platform purpose-built for ophthalmology and optometry practices, today announced a strategic integration with AdvancedMD, a leading …

BlueCloudX Awarded Patent for Groundbreaking GDPR-Compliant Credential Management System

BlueCloudX Awarded Patent for Groundbreaking GDPR-Compliant Credential Management System

The patented technology introduces GDPR wallets, a secure method for users to store and selectively share private data with authorized consumers. AUSTIN, TX, UNITED STATES, April 22, 2025 /⁨EINPresswire.com⁩/ -- BlueCloudX, a leader in privacy-first cloud …

Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

NOVATO, Calif., April 22, 2025 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for rare and ultrarare diseases, today reported the grant of …

Clover Health Announces Changes to Board of Directors

Clover Health Announces Changes to Board of Directors

WILMINGTON, Del., April 22, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that after four years of distinguished service, Lee A. Shapiro, a member of Clover Health’s …

Natural Mounjaro Recipe for Weight Loss: The Best OTC Tirzepatide Alternative, Slimjaro

Natural Mounjaro Recipe for Weight Loss: The Best OTC Tirzepatide Alternative, Slimjaro

Lakeland, Florida, April 22, 2025 (GLOBE NEWSWIRE) -- Slimjaro Emerges as the Leading Natural Mounjaro Recipe for Weight Loss in 2025—Delivering a Powerful OTC Tirzepatide Alternative Without the Injections, Prescription Costs, or Side Effects Introduction …

UNITY Biotechnology, Inc. Reports First Quarter 2025 Financial Results and Business Updates

UNITY Biotechnology, Inc. Reports First Quarter 2025 Financial Results and Business Updates

SOUTH SAN FRANCISCO, Calif., April 22, 2025 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to slow, halt, or reverse diseases of aging, today reported financial results for the first …

STERIS to Host a Conference Call for Fiscal 2025 Fourth Quarter and Full Year Financial Results on May 15, 2025

STERIS to Host a Conference Call for Fiscal 2025 Fourth Quarter and Full Year Financial Results on May 15, 2025

DUBLIN, IRELAND, April 22, 2025 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2025 fourth quarter and full year financial results at 9:00 a.m. ET on May 15, …

Viemed Healthcare Announces First Quarter 2025 Earnings Conference Call Details

Viemed Healthcare Announces First Quarter 2025 Earnings Conference Call Details

LAFAYETTE, La., April 22, 2025 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the “Company” or “Viemed”) (NASDAQ:VMD), a national leader in respiratory care and technology-enabled home medical equipment services, today announced that it will host its First …

The Oncology Institute of Hope and Innovation Expands Research Partnership with Helios Clinical Across Markets, Enhancing Access to Cutting-Edge Cancer Trials

The Oncology Institute of Hope and Innovation Expands Research Partnership with Helios Clinical Across Markets, Enhancing Access to Cutting-Edge Cancer Trials

CERRITOS, Calif., April 22, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) (“TOI” or the “Company”), a pioneer in value-based community oncology care, is proud to announce an enterprise-wide expansion of its strategic partnership with …

Abivax Announces Annual General Meeting Details as Company Advances Toward Key 2025 Value-Driving Milestones

Abivax Announces Annual General Meeting Details as Company Advances Toward Key 2025 Value-Driving Milestones

Abivax Announces Annual General Meeting Details as Company Advances Toward Key 2025 Value-Driving Milestones Annual General Meeting scheduled for Friday, June 6, 2025, in Paris, France Phase 3 ABTECT induction trials remain on track: enrollment completion …

Sight Sciences Appoints Gary Burbach to its Board of Directors

Sight Sciences Appoints Gary Burbach to its Board of Directors

MENLO PARK, Calif., April 22, 2025 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (Sight Sciences, or the Company), an eyecare technology company focused on developing and commercializing innovative, interventional technologies that elevate the …

Elutia to Participate in Chardan’s Trending Issues in Drug Development Conference Series on April 29

Elutia to Participate in Chardan’s Trending Issues in Drug Development Conference Series on April 29

SILVER SPRING, Md., April 22, 2025 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia”), a pioneer in drug-eluting biomatrix technologies, today announced that Michelle LeRoux Williams, Ph.D., Elutia’s Chief Scientific Officer, will participate in …

Intuitive Announces First Quarter Earnings

Intuitive Announces First Quarter Earnings

SUNNYVALE, Calif., April 22, 2025 (GLOBE NEWSWIRE) -- Intuitive (the “Company”) (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced financial results for the quarter ended March …

NurExone Appoints Biotech Industry Leader - Jacob Licht to Lead U.S. Operations and Exo-Top Manufacturing Expansion and Completes Continuance into Ontario

NurExone Appoints Biotech Industry Leader - Jacob Licht to Lead U.S. Operations and Exo-Top Manufacturing Expansion and Completes Continuance into Ontario

TORONTO and HAIFA, Israel, April 22, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone” or the “Company”), a preclinical-stage biotechnology company pioneering regenerative exosomes-based therapies for central …

Longeveron® Issues Letter to Shareholders Highlighting Corporate Strategy, Recent Progress and Key Priorities and Goals for 2025

Longeveron® Issues Letter to Shareholders Highlighting Corporate Strategy, Recent Progress and Key Priorities and Goals for 2025

MIAMI, April 22, 2025 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage regenerative medicine biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions, today announced that the Company …

Mesmerize honored with 2025 Pharmacy500 award by RXinsider

Mesmerize honored with 2025 Pharmacy500 award by RXinsider

NEW YORK, NY, April 22, 2025 (GLOBE NEWSWIRE) -- Mesmerize, an MJH Life Sciences® brand and a leader in patient education at the point of care, is proud to announce that it has been named to the prestigious 2025 Pharmacy500, an annual award presented by …

Pacira BioSciences to Present 104-Week Efficacy Data Following a Single Local Administration of PCRX-201 for Patients with Mild to Severe Osteoarthritis of the Knee

Pacira BioSciences to Present 104-Week Efficacy Data Following a Single Local Administration of PCRX-201 for Patients with Mild to Severe Osteoarthritis of the Knee

-- Poster to be presented at OARSI World Congress on Osteoarthritis -- BRISBANE, Calif., April 22, 2025 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service